bf/NASDAQ:SMMT_icon.jpeg

NASDAQ:SMMT

Summit Therapeutics Inc.

  • Stock

USD

Last Close

12.86

30/08 20:00

Market Cap

5.82B

Beta: −1.02

Volume Today

2.05M

Avg: 2.06M

PE Ratio

−1.63

PFCF: −51.96

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jan '14
Jan '15
Jan '16
Jan '17
Jan '18
Jan '19
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.21
-
0.08
62.57%
0.06
-
0.47
668.47%
0.72
52.78%
1.76
144.56%
0.01
99.52%
0.02
90.17%
0.00
93.35%
cash conversion cycle
-47.25K
-
-170.30K
260.43%
cash per share
0.69
-
0.43
38.20%
0.39
8.34%
0.57
45.05%
0.43
23.70%
0.41
5.48%
0.96
-
0.55
42.94%
1.80
230.82%
0.30
83.33%
company equity multiplier
1.39
-
1.30
6.93%
1.19
8.44%
-10.76
1,006.86%
5.46
150.78%
1.40
74.29%
0.57
59.10%
1.29
124.54%
1.36
5.52%
5.24
285.22%
2.61
50.19%
days of inventory outstanding
434.62
-
days of payables outstanding
47.25K
-
170.30K
260.43%
474.86
-
days of sales outstanding
147.68
-
191.13
29.42%
600.36
-
4.32K
-
3.46K
19.92%
3.17K
8.46%
dividend yield
ebit per revenue
-4.88
-
-8.44
73.06%
-10.79
-
-0.51
95.30%
0.22
143.27%
0.35
60.55%
-61.85
17,653.39%
-47.64
22.97%
-102.36
114.84%
ebt per ebit
1.00
-
1.00
0.27%
1.00
0.25%
1.03
3.59%
0.84
18.33%
0.53
36.92%
0.33
38.17%
0.99
201.87%
1.03
3.35%
1.09
6.30%
6.86
528.01%
effective tax rate
0.09
-
0.10
13.08%
0.15
48.16%
0.17
11.12%
0.35
104.75%
-0.50
243.65%
0.00
-
0.03
588.28%
0.06
101.61%
0.00
97.25%
enterprise value multiple
-2.40
-
-12.93
438.70%
-11.81
8.68%
-15.29
29.46%
-44.82
193.09%
3.74
108.34%
-1.84
149.17%
-5.07
175.61%
-3.31
34.67%
-16.31
392.77%
-18.84
15.49%
fixed asset turnover
31.98
-
27.37
14.41%
19.86
-
31.42
58.19%
69.82
122.23%
27.93
60.00%
0.67
97.59%
0.52
22.78%
0.14
73.30%
free cash flow per share
-2.02
-
-0.43
78.62%
-0.42
3.84%
0.24
158.89%
-0.33
234.05%
-0.41
25.56%
-0.70
-
-0.55
20.72%
-0.22
60.55%
-0.12
43.16%
gross profit margin
1
-
1
0%
1
-
1.00
0.27%
1.00
0.23%
1
0.04%
1
0%
1
0%
1
0%
interest coverage
-6.99
-
1.29K
18,549.53%
81.85
93.66%
-28.83
135.22%
-11.08
61.58%
22.26
300.99%
-208.60
-
-306.71
47.03%
-16.38
94.66%
-5.45
66.72%
inventory turnover
0.84
-
long term debt to capitalization
1.37
-
7.15
421.47%
0.13
98.18%
0.00
-
0.02
2,010.14%
0.80
3,905.11%
0.57
28.39%
net income per ebt
0.91
-
0.90
1.30%
0.85
5.50%
0.83
1.99%
0.65
21.25%
1.50
128.54%
1
33.16%
1.00
0.40%
0.97
2.38%
0.94
2.90%
1.00
5.75%
net profit margin
-4.43
-
-7.55
70.35%
-9.28
-
-0.28
96.98%
0.17
162.38%
0.12
33.65%
-61.28
52,875.04%
-47.62
22.28%
-105.61
121.77%
operating cash flow per share
-2.01
-
-0.43
78.51%
-0.41
3.91%
0.25
159.55%
-0.32
228.87%
-0.41
29.05%
-0.69
-
-0.55
20.36%
-0.22
60.97%
-0.12
42.40%
operating cycle
operating profit margin
-4.88
-
-8.44
73.06%
-10.79
-
-0.51
95.30%
0.22
143.27%
0.35
60.55%
-61.85
17,653.39%
-47.64
22.97%
-102.36
114.84%
payables turnover
0.01
-
0.00
72.26%
0.77
-
pretax profit margin
-4.87
-
-8.41
72.60%
-11.16
-
-0.43
96.16%
0.12
127.29%
0.12
0.74%
-61.52
53,088.35%
-48.98
20.39%
-111.86
128.38%
price fair value
3.80
-
11.87
212.63%
12.58
6.02%
-116.55
1,026.34%
45.08
138.68%
1.56
96.54%
4.11
-
4.25
3.44%
6.49
52.50%
20.82
220.87%
receivables turnover
2.47
-
1.91
22.73%
0.61
-
0.08
-
0.11
24.88%
0.12
9.25%
return on assets
-0.92
-
-0.59
36.24%
-0.68
16.32%
-0.57
16.56%
-0.13
76.76%
0.13
195.30%
0.20
62.26%
-0.51
351.60%
-0.76
47.79%
-0.11
85.26%
-3.03
2,605.54%
return on capital employed
-1.41
-
-0.81
42.28%
-0.92
13.44%
-0.93
0.93%
-0.37
60.46%
0.20
154.67%
0.58
186.57%
-0.64
211.63%
-0.98
52.53%
-0.12
88.26%
-0.49
326.46%
return on equity
-1.28
-
-0.76
40.66%
-0.81
6.50%
6.12
856.65%
-0.72
111.80%
0.18
124.50%
0.12
33.64%
-0.66
664.93%
-1.03
55.96%
-0.59
43.22%
-7.91
1,247.74%
total debt to capitalization
-0.34
-
1.26
-
0.11
91.01%
0.13
14.92%
-0.02
118.61%
0.01
124.05%
0.03
455.54%
0.80
2,386.58%
0.58
28.18%

All numbers in USD (except ratios and percentages)